Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer’s/Parkinson’s diseases
- 2 January 2024
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 30 (1) , 57-70
Abstract
In recent years, we have seen the widespread devastations and serious health complications manifested by COVID-19 globally. Although we have effectively controlled the pandemic, uncertainties persist regarding its potential long-term effects, including prolonged neurological issues. To gain comprehensive insights, we conducted a meta-analysis of mass spectrometry-based proteomics data retrieved from different studies with a total of 538 COVID-19 patients and 523 healthy controls. The meta-analysis revealed that top-enriched pathways were associated with neurological disorders, including Alzheimer’s (AD) and Parkinson’s disease (PD). Further analysis confirmed a direct correlation in the expression patterns of 24 proteins involved in Alzheimer’s and 23 proteins in Parkinson’s disease with COVID-19. Protein–protein interaction network and cluster analysis identified SNCA as a hub protein, a known biomarker for Parkinson’s disease, in both AD and PD. To the best of our knowledge, this is the first meta-analysis study providing proteomic profiling evidence linking COVID-19 to neurological complications.Keywords
This publication has 75 references indexed in Scilit:
- Construction and Analysis of Protein-Protein Interaction Network of Heroin Use DisorderScientific Reports, 2019
- CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networksBioSystems, 2015
- DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson’s diseaseCell Death & Disease, 2014
- Microparticles: A New Perspective in Central Nervous System DisordersBioMed Research International, 2014
- Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's DiseaseThe American Journal of Pathology, 2008
- Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical studyJournal of Neuroinflammation, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- An automated method for finding molecular complexes in large protein interaction networksBMC Bioinformatics, 2003
- Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 2000
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000